{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:24:33Z","timestamp":1789809873444,"version":"4.0.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T00:00:00Z","timestamp":1453852800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Genet"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12863-015-0308-7","type":"journal-article","created":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T10:11:20Z","timestamp":1453889480000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Frequent variations in cancer-related genes may play prognostic role in treatment of patients with chronic myeloid leukemia"],"prefix":"10.1186","volume":"17","author":[{"given":"Alexander V.","family":"Lavrov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina Y.","family":"Chelysheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana A.","family":"Smirnikhina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg A.","family":"Shukhov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna G.","family":"Turkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmira P.","family":"Adilgereeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey I.","family":"Kutsev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,27]]},"reference":[{"key":"308_CR1","volume-title":"The molecular biology of chronic myeloid leukemia. Review article","author":"MWN Deininger","year":"2000","unstructured":"Deininger MWN, Goldman JM, Melo JV: The molecular biology of chronic myeloid leukemia. Review article. 2000"},{"key":"308_CR2","first-page":"S257","volume":"18","author":"W Yin","year":"2012","unstructured":"Yin W, Penrod JR, Maclean R, Lakdawalla DN, Philipson T: Value of survival gains in chronic myeloid leukemia. Am J Manag Care. 2012, 18: S257-64.","journal-title":"Am J Manag Care"},{"key":"308_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/leu.2010.238","volume":"25","author":"D Bixby","year":"2011","unstructured":"Bixby D, Talpaz M: Seeking the causes and solutions to imatinib-resistance in chronic myeloid leukemia. Leukemia. 2011, 25: 7-22. 10.1038\/leu.2010.238.","journal-title":"Leukemia"},{"key":"308_CR4","volume-title":"Mechanisms of primary and secondary resistance to Imatinib in chronic myeloid leukemia","author":"A Quint\u00e1s-Cardama","year":"2009","unstructured":"Quint\u00e1s-Cardama A, Kantarjian HM, Cortes JE: Mechanisms of primary and secondary resistance to Imatinib in chronic myeloid leukemia. 2009"},{"key":"308_CR5","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1182\/blood-2013-05-501569","volume":"122","author":"M Baccarani","year":"2013","unstructured":"Baccarani M, Deininger MW, Rosti G, Hochhaus A, Soverini S, Apperley JF, et al: European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. Blood. 2013, 122: 872-84. 10.1182\/blood-2013-05-501569.","journal-title":"Blood"},{"key":"308_CR6","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.1200\/JCO.2011.37.6962","volume":"29","author":"D Marin","year":"2011","unstructured":"Marin D, Ibrahim AR, Goldman JM: European Treatment and Outcome Study (EUTOS) score for chronic myeloid leukemia still requires more confirmation. J Clin Oncol. 2011, 29: 3944-5. 10.1200\/JCO.2011.37.6962.","journal-title":"J Clin Oncol"},{"key":"308_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/cas.12321","volume":"105","author":"E Yamamoto","year":"2014","unstructured":"Yamamoto E, Fujisawa S, Hagihara M, Tanaka M, Fujimaki K, Kishimoto K, et al: European Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patients. Cancer Sci. 2014, 105: 105-9. 10.1111\/cas.12321.","journal-title":"Cancer Sci"},{"key":"308_CR8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1471-2105-10-48","volume":"10","author":"E Eden","year":"2009","unstructured":"Eden E, Navon R, Steinfeld I, Lipson D, Yakhini Z: GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics. 2009, 10: 48-10.1186\/1471-2105-10-48.","journal-title":"BMC Bioinformatics"},{"key":"308_CR9","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/bib\/bbs017","volume":"14","author":"H Thorvaldsd\u00f3ttir","year":"2013","unstructured":"Thorvaldsd\u00f3ttir H, Robinson JT, Mesirov JP: Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform. 2013, 14: 178-92. 10.1093\/bib\/bbs017.","journal-title":"Brief Bioinform"},{"key":"308_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson JT, Thorvaldsd\u00f3ttir H, Winckler W, Guttman M, Lander ES, Getz G, et al: Integrative genomics viewer. Nat Biotechnol. 2011, 29: 24-6. 10.1038\/nbt.1754.","journal-title":"Nat Biotechnol"},{"key":"308_CR11","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1101\/gr.176601","volume":"11","author":"PC Ng","year":"2001","unstructured":"Ng PC, Henikoff S: Predicting deleterious amino acid substitutions. Genome Res. 2001, 11: 863-74. 10.1101\/gr.176601.","journal-title":"Genome Res"},{"key":"308_CR12","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al: A method and server for predicting damaging missense mutations. Nat Methods. 2010, 7: 248-9. 10.1038\/nmeth0410-248.","journal-title":"Nat Methods"},{"issue":"1","key":"308_CR13","first-page":"12","volume":"6","author":"SA Smirnikhina","year":"2013","unstructured":"Smirnikhina SA, Lavrov AV, Adilgereeva EP, Turkina AG, Kutsev SI: Clinical importance of whole-exome studies using next generation sequencing in myeloid neoplasia. Clinical Oncohematology Fundamental research and clinical practice (RUS). 2013, 6 (1): 12-20.","journal-title":"Clinical Oncohematology Fundamental research and clinical practice (RUS)"},{"key":"308_CR14","doi-asserted-by":"crossref","unstructured":"Borisov NM, Terekhanova N V, Aliper AM, Venkova LS, Smirnov PY, Roumiantsev S, et al. Signaling pathway activation profiles make better markers of cancer than expression of individual genes. Oncotarget 2014; Aug 23.","DOI":"10.18632\/oncotarget.2548"},{"key":"308_CR15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1086\/510919","volume":"80","author":"E Klopocki","year":"2007","unstructured":"Klopocki E, Schulze H, Strauss G, Ott C-E, Hall J, Trotier F, et al: Complex inheritance pattern resembling autosomal recessive inheritance involving a microdeletion in thrombocytopenia-absent radius syndrome. Am J Hum Genet. 2007, 80: 232-40. 10.1086\/510919.","journal-title":"Am J Hum Genet"},{"key":"308_CR16","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1074\/mcp.M500112-MCP200","volume":"4","author":"RR Miles","year":"2005","unstructured":"Miles RR, Crockett DK, Lim MS, Elenitoba-Johnson KSJ: Analysis of BCL6-interacting proteins by tandem mass spectrometry. Mol Cell Proteomics. 2005, 4: 1898-909. 10.1074\/mcp.M500112-MCP200.","journal-title":"Mol Cell Proteomics"},{"key":"308_CR17","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/mgg3.23","volume":"1","author":"R Spinelli","year":"2013","unstructured":"Spinelli R, Pirola A, Redaelli S, Sharma N, Raman H, Valletta S, et al: Identification of novel point mutations in splicing sites integrating whole-exome and RNA-seq data in myeloproliferative diseases. Mol Genet Genomic Med. 2013, 1: 246-59. 10.1002\/mgg3.23.","journal-title":"Mol Genet Genomic Med"},{"key":"308_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s11596-014-1255-7","volume":"34","author":"L He","year":"2014","unstructured":"He L, Ji J, Liu S, Xue E, Liang Q, Ma Z: Expression of cancer-testis antigen in multiple myeloma. J Huazhong Univ Sci Technolog Med Sci. 2014, 34: 181-5. 10.1007\/s11596-014-1255-7.","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"308_CR19","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1158\/2326-6066.CIR-13-0124","volume":"2","author":"Y-T Chen","year":"2014","unstructured":"Chen Y-T, Panarelli NC, Piotti KC, Yantiss RK: Cancer-testis antigen expression in digestive tract carcinomas: frequent expression in esophageal squamous cell carcinoma and its precursor lesions. Cancer Immunol Res. 2014, 2: 480-6. 10.1158\/2326-6066.CIR-13-0124.","journal-title":"Cancer Immunol Res"},{"key":"308_CR20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3892\/or.2014.3195","volume":"32","author":"Y Akiyama","year":"2014","unstructured":"Akiyama Y, Ashizawa T, Komiyama M, Miyata H, Oshita C, Omiya M, et al: YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line. Oncol Rep. 2014, 32: 159-66.","journal-title":"Oncol Rep"},{"key":"308_CR21","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/modpathol.2012.32","volume":"25","author":"SS Koh","year":"2012","unstructured":"Koh SS, Wei J-PJ, Li X, Huang RR, Doan NB, Scolyer RA, et al: Differential gene expression profiling of primary cutaneous melanoma and sentinel lymph node metastases. Mod Pathol. 2012, 25: 828-37. 10.1038\/modpathol.2012.32.","journal-title":"Mod Pathol"},{"key":"308_CR22","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00262-012-1376-4","volume":"62","author":"F de Carvalho","year":"2013","unstructured":"de Carvalho F, Alves VLF, Braga WMT, Xavier CV, Colleoni GWB: MAGE-C1\/CT7 and MAGE-C2\/CT10 are frequently expressed in multiple myeloma and can be explored in combined immunotherapy for this malignancy. Cancer Immunol Immunother. 2013, 62: 191-5. 10.1007\/s00262-012-1376-4.","journal-title":"Cancer Immunol Immunother"},{"key":"308_CR23","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3324\/haematol.2009.014464","volume":"95","author":"D Atanackovic","year":"2010","unstructured":"Atanackovic D, Hildebrandt Y, Jadczak A, Cao Y, Luetkens T, Meyer S, et al: Cancer-testis antigens MAGE-C1\/CT7 and MAGE-A3 promote the survival of multiple myeloma cells. Haematologica. 2010, 95: 785-93. 10.3324\/haematol.2009.014464.","journal-title":"Haematologica"},{"key":"308_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12885-015-1018-2","volume":"15","author":"A Seksenyan","year":"2015","unstructured":"Seksenyan A, Kadavallore A, Walts AE, de la Torre B, Berel D, Strom SP, et al: TOX3 is expressed in mammary ER(+) epithelial cells and regulates ER target genes in luminal breast cancer. BMC Cancer. 2015, 15: 22-10.1186\/s12885-015-1018-2.","journal-title":"BMC Cancer"},{"key":"308_CR25","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.1007\/s11033-014-3236-0","volume":"41","author":"I Elematore","year":"2014","unstructured":"Elematore I, Gonzalez-Hormazabal P, Reyes JM, Blanco R, Bravo T, Peralta O, et al: Association of genetic variants at TOX3, 2q35 and 8q24 with the risk of familial and early-onset breast cancer in a South-American population. Mol Biol Rep. 2014, 41: 3715-22. 10.1007\/s11033-014-3236-0.","journal-title":"Mol Biol Rep"},{"key":"308_CR26","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1158\/1055-9965.EPI-14-0129","volume":"23","author":"SL Park","year":"2014","unstructured":"Park SL, Caberto CP, Lin Y, Goodloe RJ, Dumitrescu L, Love S-A, et al: Association of cancer susceptibility variants with risk of multiple primary cancers: the population architecture using genomics and epidemiology study. Cancer Epidemiol Biomarkers Prev. 2014, 23: 2568-78. 10.1158\/1055-9965.EPI-14-0129.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"308_CR27","doi-asserted-by":"publisher","first-page":"4317","DOI":"10.1182\/blood-2005-09-3747","volume":"107","author":"S Takayanagi","year":"2006","unstructured":"Takayanagi S, Hiroyama T, Yamazaki S, Nakajima T, Morita Y, Usui J, et al: Genetic marking of hematopoietic stem and endothelial cells: identification of the Tmtsp gene encoding a novel cell surface protein with the thrombospondin-1 domain. Blood. 2006, 107: 4317-25. 10.1182\/blood-2005-09-3747.","journal-title":"Blood"},{"key":"308_CR28","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3892\/ijo.2012.1500","volume":"41","author":"A Khamas","year":"2012","unstructured":"Khamas A, Ishikawa T, Mogushi K, Iida S, Ishiguro M, Tanaka H, et al: Genome-wide screening for methylation-silenced genes in colorectal cancer. Int J Oncol. 2012, 41: 490-6.","journal-title":"Int J Oncol"},{"key":"308_CR29","first-page":"11","volume":"6","author":"H Takeshima","year":"2000","unstructured":"Takeshima H, Komazaki S, Nishi M, Iino M, Kangawa K: Junctophilins: a novel family of junctional membrane complex proteins. Mol Cell. 2000, 6: 11-22.","journal-title":"Mol Cell"},{"key":"308_CR30","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.chom.2014.08.002","volume":"16","author":"P Abnave","year":"2014","unstructured":"Abnave P, Mottola G, Gimenez G, Boucherit N, Trouplin V, Torre C, et al: Screening in planarians identifies MORN2 as a key component in LC3-associated phagocytosis and resistance to bacterial infection. Cell Host Microbe. 2014, 16: 338-50. 10.1016\/j.chom.2014.08.002.","journal-title":"Cell Host Microbe"},{"key":"308_CR31","volume-title":"PLoS One","author":"KL Mecklenburg","year":"2015","unstructured":"Mecklenburg KL, Freed SA, Raval M, Quintero OA, Yengo CM, O\u2019Tousa JE: Invertebrate and vertebrate class III myosins interact with MORN repeat-containing adaptor proteins. PLoS One. 2015, 10: 10.1371\/journal.pone.0122502. Article ID e0122502"},{"key":"308_CR32","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1093\/nar\/gku1340","volume":"43","author":"RM Rodriguez","year":"2015","unstructured":"Rodriguez RM, Suarez-Alvarez B, Mos\u00e9n-Ansorena D, Garc\u00eda-Peydr\u00f3 M, Fuentes P, Garc\u00eda-Le\u00f3n MJ, et al: Regulation of the transcriptional program by DNA methylation during human \u03b1\u03b2 T-cell development. Nucleic Acids Res. 2015, 43: 760-74. 10.1093\/nar\/gku1340.","journal-title":"Nucleic Acids Res"},{"key":"308_CR33","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/ni.2590","volume":"14","author":"M Mingueneau","year":"2013","unstructured":"Mingueneau M, Kreslavsky T, Gray D, Heng T, Cruse R, Ericson J, et al: The transcriptional landscape of \u03b1\u03b2 T cell differentiation. Nat Immunol. 2013, 14: 619-32. 10.1038\/ni.2590.","journal-title":"Nat Immunol"},{"key":"308_CR34","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1182\/blood-2005-09-009977","volume":"108","author":"E Chapiro","year":"2006","unstructured":"Chapiro E, Delabesse E, Asnafi V, Millien C, Davi F, Nugent E, et al: Expression of T-lineage-affiliated transcripts and TCR rearrangements in acute promyelocytic leukemia: implications for the cellular target of t(15;17). Blood. 2006, 108: 3484-93. 10.1182\/blood-2005-09-009977.","journal-title":"Blood"},{"key":"308_CR35","volume-title":"Nucleic Acids Res","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H: ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010, 38: 10.1093\/nar\/gkq603. Article ID e164"},{"key":"308_CR36","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1093\/bioinformatics\/btq330","volume":"26","author":"W McLaren","year":"2010","unstructured":"McLaren W, Pritchard B, Rios D, Chen Y, Flicek P, Cunningham F: Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. Bioinformatics. 2010, 26: 2069-70. 10.1093\/bioinformatics\/btq330.","journal-title":"Bioinformatics"}],"container-title":["BMC Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12863-015-0308-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12863-015-0308-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12863-015-0308-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T01:27:13Z","timestamp":1567560433000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcgenet.biomedcentral.com\/articles\/10.1186\/s12863-015-0308-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,27]]},"references-count":36,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["308"],"URL":"https:\/\/doi.org\/10.1186\/s12863-015-0308-7","relation":{},"ISSN":["1471-2156"],"issn-type":[{"value":"1471-2156","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,27]]},"article-number":"S14"}}